This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Access the science, technology and contacts that you need to accelerate your biologics and novel products towards commercial success.

Formulation development of microbiome therapeutics localized in the intestines

Share this article

Microbiome drugs are delivered to specific locations within the gastrointestinal tract, so they must be formulated for targeted release without systemic absorption. With few examples on the market, formulation is a growing concern for developers of these medicines.

In this article from BioProcess International, the authors from Synthetic Biologics describe the rationale, design, and evaluation of microbiome products, while discussing challenges and possible solutions for localized intestinal delivery.

Read the full article here...

Share this article

Upcoming event

BioProcess International Europe

09 - 12 May 2023, RAI in Amsterdam

Europe’s Leading BioProcessing Event for Accelerating Next Generation mAbs, Novel Modalities and ATMPs to Commercial Success

Go to site